Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether
CAS:
Rif. 3D-FL146829
Informazioni sul prodotto
Nome:Lithium hexamethyl disilazide solution - 1 M in tert-butyl methyl ether
Sinonimi:
- 1,1,1,3,3,3-Hexamethyldisilazane lithium saltLithium bis(trimethylsilyl)amide
Marchio:Biosynth
Descrizione:Lithium hexamethyl disilazide solution is an inhibitor drug that blocks the synthesis of pyrimidine compounds. It has been shown to be effective in congestive heart failure, hyperproliferative diseases such as pancreatitis and dyslipoproteinemia, coronary heart diseases, and HIV infection. Lithium hexamethyl disilazide solution binds to the cb2 receptor on the surface of activated T cells, which inhibits their ability to cause inflammation or autoimmune disease. This drug also has nitrogen atoms that are reactive and asymmetric, making it a good candidate for an inhibitor drug.
Avviso:I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Proprietà chimiche
Peso molecolare:167.33 g/mol
Formula:C6H18LiNSi2
Purezza:Min. 95%